JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Immunotherapy in Multiple Myeloma.

OBJECTIVES: To review the use of monoclonal antibodies (mAbs) in the treatment of multiple myeloma (MM) and the management of most common side effects.

DATA SOURCES: Review of journal articles related to mAbs in MM.

CONCLUSION: The therapeutic options for MM have improved dramatically and the development of mAbs has been associated with improvement in clinical outcomes and favorable toxicity profiles.

IMPLICATIONS FOR NURSING PRACTICE: With appropriate pre-medications and nursing management, mAbs are a well-tolerated treatment option for myeloma patients.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app